We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

76 hedge funds and large institutions have $753M invested in Dyne Therapeutics in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 14

41% more capital invested

Capital invested by funds: $533M → $753M (+$220M)

3.19% more ownership

Funds ownership: 66.73% → 69.92% (+3.2%)

1% more funds holding

Funds holding: 75 → 76 (+1)

7% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 14

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
1.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
29
Reduced
14
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.7M
2
GPP
Great Point Partners
Connecticut
+$12.6M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.41M
4
MWNA
Marshall Wace North America
New York
+$6.2M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.16M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$21.6M
2
CC
Casdin Capital
New York
-$9.47M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$5.58M
4
Citadel Advisors
Citadel Advisors
Florida
-$3.37M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
26
Commodore Capital
New York
$6.42M -$2.35M -124,987 -29%
Northern Trust
27
Northern Trust
Illinois
$5.69M +$1.78M +94,786 +54%
WP
28
Woodline Partners
California
$4.68M -$3.01M -160,119 -42%
EC
29
EcoR1 Capital
California
$4.52M – – –
Balyasny Asset Management
30
Balyasny Asset Management
Illinois
$4.1M +$3.67M +195,052 New
Goldman Sachs
31
Goldman Sachs
New York
$3.83M +$1.5M +79,633 +78%
SCM
32
Soleus Capital Management
Connecticut
$3.75M +$75.2K +4,000 +2%
ACH
33
ArrowMark Colorado Holdings
Colorado
$3.54M +$1.29M +68,500 +69%
ACM
34
Altium Capital Management
New York
$3.51M – – –
N
35
Nuveen
North Carolina
$3.19M +$2.07M +110,223 +266%
Charles Schwab
36
Charles Schwab
California
$3.19M +$548K +29,134 +24%
IBT
37
International Biotechnology Trust
United Kingdom
$2.84M +$773K +41,114 +44%
Alyeska Investment Group
38
Alyeska Investment Group
Illinois
$2.64M – – –
HMC
39
Harvard Management Company
Massachusetts
$2.26M – – –
Adage Capital Partners
40
Adage Capital Partners
Massachusetts
$2.1M +$1.88M +100,000 New
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.07M +$959K +51,000 New
TRSOTSOK
42
Teachers Retirement System of the State of Kentucky
Kentucky
$1.04M -$238K -12,676 -20%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$871K +$322K +17,111 +70%
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$842K – – –
MS
45
Maven Securities
Jersey
$798K -$1.03M -54,966 -60%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$795K +$711K +37,806 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$778K +$478K +25,442 +220%
Two Sigma Advisers
48
Two Sigma Advisers
New York
$545K -$196K -10,400 -29%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$543K +$290K +15,430 +148%
Tudor Investment Corp
50
Tudor Investment Corp
Connecticut
$489K -$950K -50,528 -69%
1
2
3 4

DYN Hedge Fund Activity: Q2 2021 in Review

76 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2021, worth a combined $753M — up 41% from $533M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new DYN positions and 14 closed out — a net gain of 1 holder — while 29 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $13.7M. The largest seller was Logos Global Management, cutting an estimated $21.6M.

  • 76 institutional investors held Dyne Therapeutics (DYN) as of Q2 2021, up from 75 in Q1 2021.
  • Funds reported $753M of Dyne Therapeutics stock for Q2 2021, up 41% quarter-over-quarter.
  • 15 funds opened new Dyne Therapeutics positions in Q2 2021 and 14 closed out, a net change of +1 holder.
  • The largest Dyne Therapeutics buyer in Q2 2021 was BlackRock, an estimated $13.7M added.
  • The largest Dyne Therapeutics seller in Q2 2021 was Logos Global Management, an estimated $21.6M sold.

Based on aggregated 13F filings for Q2 2021.